Medical device maker AtriCure (NASDAQ:ATRC) is looking to obtain regulatory clearance to use its AtriClip heart device on stroke patients. The Cincinnati-area company is planning next year to begin a ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and ...
WEST CHESTER, Ohio — AtriCure has received approval in Europe for its AtriClip, a device that protects against clotting during certain heart procedures. Europe’s granting of the CE Mark for the ...
MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced U.S. Food and Drug ...
Cleveland, OH - The AtriClip Gillinov-Cosgrove Left Atrial Appendage (LAA) Exclusion system (AtriCure, West Chester, OH) has been approved by the US FDA for occlusion of the LAA, under direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results